Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ishrat Jabeen

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Current Cancer Drug Targets|July 4, 2017
Pharmacoinformatic Approaches to Design Novel Inhibitors of Protein Kinase B Pathways in CancerNoreen Akhtar, Ishrat Jabeen
Peerj|February 7, 2019
GRID-independent molecular descriptor analysis and molecular docking studies to mimic the binding hypothesis of γ-aminobutyric acid transporter 1 (GAT1) inhibitorsSadia Zafar, Ishrat Jabeen
Molecules (Basel, Switzerland)|October 21, 2020
Molecular Dynamic Simulations to Probe Stereoselectivity of Tiagabine Binding with Human GAT1Sadia Zafar, Ishrat Jabeen
Current Cancer Drug Targets|September 3, 2016
Grid-independent Descriptors (GRIND) Analysis and SAR Guided Molecular Docking Studies to Probe Selectivity Profiles of Inhibitors of Multidrug Resistance Transporters ABCB1 and ABCG2Talha Shafi, Ishrat Jabeen
Plos One|December 31, 2016
A 2D-QSAR and Grid-Independent Molecular Descriptor (GRIND) Analysis of Quinoline-Type Inhibitors of Akt2: Exploration of the Binding Mode in the Pleckstrin Homology (PH) DomainNoreen Akhtar, Ishrat Jabeen
International Journal of Molecular Sciences|December 10, 2021
Combined Pharmacophore and Grid-Independent Molecular Descriptors (GRIND) Analysis to Probe 3D Features of Inositol 1,4,5-Trisphosphate Receptor (IP<sub>3</sub>R) Inhibitors in CancerHumaira Ismatullah, Ishrat Jabeen
Frontiers in Chemistry|September 27, 2018
Structure, Function, and Modulation of γ-Aminobutyric Acid Transporter 1 (GAT1) in Neurological Disorders: A Pharmacoinformatic ProspectiveSadia Zafar, Ishrat Jabeen
Frontiers in Pharmacology|March 18, 2022
Combined Machine Learning and GRID-Independent Molecular Descriptor (GRIND) Models to Probe the Activity Profiles of 5-Lipoxygenase Activating Protein InhibitorsHafiza Aliza Khan, Ishrat Jabeen
Methods in Molecular Biology (Clifton, N.J.)|July 10, 2024
Challenges of Protein-Protein Docking of the Membrane ProteinsYusra Sajid Kiani, Ishrat Jabeen
ACS Omega|January 21, 2020
Lipophilic Metabolic Efficiency (LipMetE) and Drug Efficiency Indices to Explore the Metabolic Properties of the Substrates of Selected Cytochrome P450 IsoformsYusra Sajid Kiani, Ishrat Jabeen
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Current Cancer Drug Targets|July 4, 2017
Pharmacoinformatic Approaches to Design Novel Inhibitors of Protein Kinase B Pathways in CancerNoreen Akhtar, Ishrat Jabeen
Peerj|February 7, 2019
GRID-independent molecular descriptor analysis and molecular docking studies to mimic the binding hypothesis of γ-aminobutyric acid transporter 1 (GAT1) inhibitorsSadia Zafar, Ishrat Jabeen
Molecules (Basel, Switzerland)|October 21, 2020
Molecular Dynamic Simulations to Probe Stereoselectivity of Tiagabine Binding with Human GAT1Sadia Zafar, Ishrat Jabeen
Current Cancer Drug Targets|September 3, 2016
Grid-independent Descriptors (GRIND) Analysis and SAR Guided Molecular Docking Studies to Probe Selectivity Profiles of Inhibitors of Multidrug Resistance Transporters ABCB1 and ABCG2Talha Shafi, Ishrat Jabeen
Plos One|December 31, 2016
A 2D-QSAR and Grid-Independent Molecular Descriptor (GRIND) Analysis of Quinoline-Type Inhibitors of Akt2: Exploration of the Binding Mode in the Pleckstrin Homology (PH) DomainNoreen Akhtar, Ishrat Jabeen
International Journal of Molecular Sciences|December 10, 2021
Combined Pharmacophore and Grid-Independent Molecular Descriptors (GRIND) Analysis to Probe 3D Features of Inositol 1,4,5-Trisphosphate Receptor (IP<sub>3</sub>R) Inhibitors in CancerHumaira Ismatullah, Ishrat Jabeen
Frontiers in Chemistry|September 27, 2018
Structure, Function, and Modulation of γ-Aminobutyric Acid Transporter 1 (GAT1) in Neurological Disorders: A Pharmacoinformatic ProspectiveSadia Zafar, Ishrat Jabeen
Frontiers in Pharmacology|March 18, 2022
Combined Machine Learning and GRID-Independent Molecular Descriptor (GRIND) Models to Probe the Activity Profiles of 5-Lipoxygenase Activating Protein InhibitorsHafiza Aliza Khan, Ishrat Jabeen
Methods in Molecular Biology (Clifton, N.J.)|July 10, 2024
Challenges of Protein-Protein Docking of the Membrane ProteinsYusra Sajid Kiani, Ishrat Jabeen
ACS Omega|January 21, 2020
Lipophilic Metabolic Efficiency (LipMetE) and Drug Efficiency Indices to Explore the Metabolic Properties of the Substrates of Selected Cytochrome P450 IsoformsYusra Sajid Kiani, Ishrat Jabeen
Pageof 6